118 related articles for article (PubMed ID: 9873482)
41. Broadband detection electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry to reveal enzymatically and chemically induced deamidation reactions within peptides.
Schmid DG; von der Mülbe FD; Fleckenstein B; Weinschenk T; Jung G
Anal Chem; 2001 Dec; 73(24):6008-13. PubMed ID: 11791573
[TBL] [Abstract][Full Text] [Related]
42. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
Skovbjerg H; Koch C; Anthonsen D; Sjöström H
Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
[TBL] [Abstract][Full Text] [Related]
43. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
[TBL] [Abstract][Full Text] [Related]
44. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
Aleanzi M; Demonte AM; Esper C; Garcilazo S; Waggener M
Clin Chem; 2001 Nov; 47(11):2023-8. PubMed ID: 11673371
[TBL] [Abstract][Full Text] [Related]
45. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
Lundin KE; Scott H; Hansen T; Paulsen G; Halstensen TS; Fausa O; Thorsby E; Sollid LM
J Exp Med; 1993 Jul; 178(1):187-96. PubMed ID: 8315377
[TBL] [Abstract][Full Text] [Related]
46. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
47. Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer.
Kooy-Winkelaar Y; van Lummel M; Moustakas AK; Schweizer J; Mearin ML; Mulder CJ; Roep BO; Drijfhout JW; Papadopoulos GK; van Bergen J; Koning F
J Immunol; 2011 Nov; 187(10):5123-9. PubMed ID: 22013116
[TBL] [Abstract][Full Text] [Related]
48. Pathomechanisms in celiac disease.
Dieterich W; Esslinger B; Schuppan D
Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
[TBL] [Abstract][Full Text] [Related]
49. Identification of a putative motif for binding of peptides to HLA-DQ2.
Johansen BH; Vartdal F; Eriksen JA; Thorsby E; Sollid LM
Int Immunol; 1996 Feb; 8(2):177-82. PubMed ID: 8671602
[TBL] [Abstract][Full Text] [Related]
50. Assessment method for deamidation in proteins using carboxylic acid derivatization-liquid chromatography-tandem mass spectrometry.
Kawasue S; Sakaguchi Y; Koga R; Yoshida H; Nohta H
J Pharm Biomed Anal; 2020 Mar; 181():113095. PubMed ID: 31962249
[TBL] [Abstract][Full Text] [Related]
51. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
Kim CY; Quarsten H; Bergseng E; Khosla C; Sollid LM
Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4175-9. PubMed ID: 15020763
[TBL] [Abstract][Full Text] [Related]
52. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
[TBL] [Abstract][Full Text] [Related]
53. In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.
Anderson RP; Degano P; Godkin AJ; Jewell DP; Hill AV
Nat Med; 2000 Mar; 6(3):337-42. PubMed ID: 10700238
[TBL] [Abstract][Full Text] [Related]
54. Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay.
Shidrawi RG; Parnell ND; Ciclitira PJ; Travers P; Evan G; Rosen-Bronson S
Clin Exp Immunol; 1998 Jan; 111(1):158-65. PubMed ID: 9472676
[TBL] [Abstract][Full Text] [Related]
55. Monitoring of in vitro deamidation of gliadin peptic fragment by mass spectrometry may reflect one of the molecular mechanisms taking place in celiac disease development.
Novák P; Man P; Tucková L; Tlaskalová-Hogenová H; Bezouska K; Havlícek V
J Mass Spectrom; 2002 May; 37(5):507-11. PubMed ID: 12112756
[TBL] [Abstract][Full Text] [Related]
56. The HLA molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 share an extensive overlap in peptide binding specificity.
Sidney J; del Guercio MF; Southwood S; Sette A
J Immunol; 2002 Nov; 169(9):5098-108. PubMed ID: 12391226
[TBL] [Abstract][Full Text] [Related]
57. Gliadin peptides activate blood monocytes from patients with celiac disease.
Cinova J; Palová-Jelínková L; Smythies LE; Cerná M; Pecharová B; Dvorák M; Fruhauf P; Tlaskalová-Hogenová H; Smith PD; Tucková L
J Clin Immunol; 2007 Mar; 27(2):201-9. PubMed ID: 17260166
[TBL] [Abstract][Full Text] [Related]
58. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.
van de Wal Y; Kooy YM; van Veelen PA; Peña SA; Mearin LM; Molberg O; Lundin KE; Sollid LM; Mutis T; Benckhuijsen WE; Drijfhout JW; Koning F
Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10050-4. PubMed ID: 9707598
[TBL] [Abstract][Full Text] [Related]
59. The estimation of glutaminyl deamidation and aspartyl cleavage rates in glucagon.
Joshi AB; Kirsch LE
Int J Pharm; 2004 Apr; 273(1-2):213-9. PubMed ID: 15010145
[TBL] [Abstract][Full Text] [Related]
60. Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein.
Jüse U; Fleckenstein B; Bergseng E; Sollid LM
Immunogenetics; 2009 Feb; 61(2):81-9. PubMed ID: 18987854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
